EU Actions ‘Will Weaken IP And Undermine Innovation’

PhRMA Attacks Commission’s Pharmaceutical Strategy

 
• By Ian Schofield
  
intellectual property concept
The EU's policies on pharma IP and incentives are under fire • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography